Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|February 28, 2015
Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)Patric J Jansson, Tetsuo Yamagishi, Akanksha Arvind, et al.
Biochimica Et Biophysica Acta|November 26, 2013
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapyBernard A Fang, Žaklina Kovačević, Kyung Chan Park, et al.
Clinical Science (London, England : 1979)|April 30, 2016
Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxiaShannon Chiang, Zaklina Kovacevic, Sumit Sahni, et al.
Cancers|July 27, 2022
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug TargetJosef Gillson, Yomna S Abd El-Aziz, Lionel Y W Leck, et al.
Carcinogenesis|May 15, 2013
Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motorsJing Sun, Daohai Zhang, Dong-Hun Bae, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2020
Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancerSumit Sahni, Elizabeth A Moon, Viive M Howell, et al.
Cancer Medicine|January 9, 2025
FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict SurvivalNathalie B Rasko, Christopher B Nahm, John Turchini, et al.
The Journal of Biological Chemistry|January 7, 2018
Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazonesLina Al-Akra, Dong-Hun Bae, Sumit Sahni, et al.
Pancreas|May 2, 2024
Lipase-to-Amylase Ratio for the Prediction of Clinically Relevant Postoperative Pancreatic Fistula Following PancreaticoduodenectomyJuanita N Chui, William A Ziaziaris, Christopher B Nahm, et al.
Pharmacological Research|August 31, 2015
The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "Triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazonesPatric J Jansson, Danuta S Kalinowski, Darius J R Lane, et al.
Pageof 9